Category: Dkoding

Skye Bioscience Reports Enhanced Intraocular Pressure-Lowering of SBI-100 Formulation Published in Peer-Reviewed Journal

By DKODING International Journal of Pharmaceutics reports advantageous performance of glaucoma drug candidate compared to standard of care in preclinical study San Diego, California, May 05, 2022 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing proprietary, synthetic cannabinoid derivatives to treat glaucoma and other diseases with significant […]

World Lupus Federation Global Survey of People Living with Lupus finds 87% Report at Least One Major Organ Affected by the Disease

By DKODING Lupus is a chronic autoimmune disease that can cause inflammation and pain in any part of the body where the immune system, which usually fights infections, attacks healthy tissue instead. Nearly three-quarters of respondents reported multiple organs impacted, with an average of three organs affected. Skin (60%) and bones (45%) were the most […]